Establishes a long COVID-19 review board to study and report on long COVID in New York.
The bill establishes a long COVID-19 review board within the New York State Department of Health. The board will review research and data on long COVID, identify disparities, review treatment protocols, develop strategies to reduce risk, and advance prevention, diagnosis, treatment, and interventions for long COVID. The board will be composed of at least fifteen members appointed by the commissioner, including experts in virology, immunology, COVID-19, and public health.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.